Effect of esketamine on reducing postpartum pain and depression
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
In this editorial, we comment on a recent article by Chen et al , that addressed the effect of intraoperative injection of esketamine on postoperative analgesia and postoperative rehabilitation after cesarean section. Poor management of post-cesarean pain is associated with decreased maternal care for the baby, longer hospitalization, and higher risk of developing postpartum depression. Esketamine is a more potent S-enantiomer of ketamine which has shown promising analgesic and antidepressant properties for managing post-cesarean pain and depression in clinical studies. However, due to its potential adverse effects on the neurological and hemodynamic status of patients, it is recommended that its usage in low doses should be limited to cesarean candidates experiencing unbearable pain. Before any recommendation for routine perioperative use of esketamine, more standardized clinical trials are needed to strengthen our existing knowledge of its effectiveness in reducing postpartum pain and depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Perioperative studies in cesarean delivery extend this risk–benefit profile beyond treatment-resistant depression, suggesting that low-dose esketamine may reduce post-cesarean pain and postpartum depressive symptoms while still requiring caution because of neurological and hemodynamic adverse effects [60].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review
Molero, P., Ramos-Quiroga, J. A., Martin-Santos, R., Calvo-Sánchez, E., Gutiérrez-Rojas, L., & Meana, J. J. (2018) · CNS Drugs · doi:10.1007/s40263-018-0519-3 · Cited by 280
Esketamine for treatment resistant depression
Swainson, J., Thomas, R. K., Archer, S., Chrenek, C., MacKay, M.-A., Baker, G., Dursun, S., Klassen, L. J., Chokka, P., & Demas, M. L. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1640604 · Cited by 151
Research works printed but not linked: 17
- 10.1016/j.jclinane.2019.109697 · DOI
- 10.12688/f1000research.13895.1 · DOI
- 10.1016/j.ajog.2019.04.012 · DOI · Paper page
- 10.1097/AJP.0b013e3181bff86d · DOI
- 10.1186/s12871-024-02450-8 · DOI
- 10.1186/s12871-024-02436-6 · DOI
- 10.1097/00000542-200208000-00029 · DOI
- 10.21037/apm-21-3343 · DOI
- 10.1016/j.psychres.2024.115765 · DOI
- 10.36076/ppj.2020/23/135 · DOI
- 10.12998/wjcc.v12.i28.6195 · DOI
- 10.1001/jamanetworkopen.2023.9321 · DOI
- 10.2147/DDDT.S460924 · DOI
- 10.1186/s12884-021-04229-y · DOI
- 10.3389/fpsyt.2022.1038379 · DOI
- 10.1016/j.psychres.2016.02.022 · DOI
- 10.1002/jnr.24312 · DOI
Cited by
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Metadata
- Authors
- Lucke-Wold, B., & Karamian, A.
- Venue
- World Journal of Clinical Cases
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2025-03-06
- Volume
- 13
- Issue
- 7
- ISSN
- 2307-8960
- Cited by
- 8
- References
- 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of esketamine on reducing postpartum pain and depression. https://app.cochat.ai/papers/10.12998/wjcc.v13.i7.100422
- The paper
- Lucke-Wold, B., & Karamian, A. (2025). Effect of esketamine on reducing postpartum pain and depression. World Journal of Clinical Cases. https://doi.org/10.12998/wjcc.v13.i7.100422
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.